HSA — authorised 17 August 2017
- Marketing authorisation holder: WYETH PHARMS INC
- Status: likely_approved
HSA authorised Besponsa on 17 August 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 17 August 2017.
WYETH PHARMS INC holds the Singaporean marketing authorisation.